"We know the exact subgroup of the immune system and we've identified the key fragments in the internal core of the virus. These should be included in a vaccine," Ajit Lalvani, the leader of the group said.
Seasonal flu kills between 2,50,000 and 5,00,000 people each year and new pandemics have the potential to take doctors by surprise. The influenza virus is constantly shifting target making seasonal vaccines useless and new ones needed each year.
Their discovery has been published in the Nature Medicine journal.
This vaccine would take a distinct approach compared with other forms of vaccination, such as the MMR jab. The new vaccine will trigger the immune system to produce antibodies that can attack an invader.
Also Read
Researchers admit it is harder to develop this kind of vaccine than to provoke an antibody response. The challenge will be to get a big enough T-cell response to offer protection and a response that will last.
Sarah Gilbert, who is also trying to develop an universal flu vaccine at the Jenner Institute in Oxford, said, "Live attenuated influenza vaccines which are given by nasal spray and will be used in children in the UK from this autumn are much better at increasing the number of influenza-specific T-cells."
"The new publication contains information on the precise characteristics of the influenza-specific T-cells which were protective, and this information will be useful in monitoring the immune response to vaccination when testing novel influenza vaccines which are designed to provide protection against pandemic as well as seasonal influenza viruses," Gilbert said.